Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bolt Biotherapeutics, Inc.

0.3500
+0.01805.42%
Post-market: 0.36000.0100+2.86%19:13 EDT
Volume:35.52K
Turnover:12.18K
Market Cap:13.42M
PE:-0.21
High:0.3600
Open:0.3491
Low:0.3320
Close:0.3320
Loading ...

BRIEF-Bolt Biotherapeutics Inc - On Jan 2, Co's Transfer To Nasdaq Capital Market Approved

Reuters
·
04 Jan

Bolt Biotherapeutics Inc - on Jan 2, Co's Transfer to Nasdaq Capital Market Approved

THOMSON REUTERS
·
04 Jan

Bolt Biotherapeutics Announces Board Changes and Appointments

TIPRANKS
·
24 Dec 2024

Bolt Metals Revises Quebec Flow-Through Offering

TIPRANKS
·
20 Dec 2024

Bolt Metals Positioned Amid Critical Minerals Crisis

TIPRANKS
·
11 Dec 2024

Bolt Metals Acquires Promising Northwind Property

TIPRANKS
·
05 Dec 2024

We Think Bolt Biotherapeutics (NASDAQ:BOLT) Needs To Drive Business Growth Carefully

Simply Wall St.
·
30 Nov 2024

Bolt Metals Poised for Growth with Copper’s New Status

TIPRANKS
·
27 Nov 2024

Bolt Biotherapeutics Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.
·
15 Nov 2024

Bolt Biotherapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
15 Nov 2024

Bolt Biotherapeutics’ Restructuring Faces Potential Setbacks: A Closer Look

TIPRANKS
·
14 Nov 2024

Bolt Biotherapeutics Reports Q3 2024 Financial Results

TIPRANKS
·
14 Nov 2024

Bolt Biotherapeutics Inc expected to post a loss of 33 cents a share - Earnings Preview

Reuters
·
13 Nov 2024

H.C. Wainwright Reaffirms Their Hold Rating on Bolt Biotherapeutics (BOLT)

TIPRANKS
·
13 Nov 2024

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
13 Nov 2024

Bolt Biotherapeutics Q3 2024 GAAP EPS $(0.40) Misses $(0.35) Estimate, Sales $1.141M Miss $1.263M Estimate

Benzinga
·
13 Nov 2024

Bolt Biotherapeutics Inc.: Q3 Earnings Snapshot

Associated Press Finance
·
13 Nov 2024

Bolt Biotherapeutics Inc: Cash Balance of $84.4 Mln as of September 30, 2024 Anticipated to Fund Key Milestones Through Mid-2026

THOMSON REUTERS
·
13 Nov 2024

Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire
·
13 Nov 2024

Here's Why We're Watching Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Situation

Simply Wall St.
·
09 Nov 2024